STD testing market to experience a thrust with increasing healthcare expenditure

Allied Market Research published a report titled “Global Market for Diagnostic Testing of Sexually Transmitted Diseases (STDs) (Disease Types, Testing Volume, Testing Devices and Geography) - Industry Analysis and Forecast, 2013 – 2020.” As per the report, the diagnostic testing market for sexually transmitted diseases would attain a size of $167.4 billion by the year 2020 with an 8.5% CAGR during 2014-2020. This significant increase of the market value is due to rise in the cases of HPV and HIV testing in African and Asia-Pacific region.

The factors driving the growth of this market are increasing fatal STDs along with high cost, and constant employment of Client-Initiated Counselling and Testing (CICT) & Provider-Initiated Counselling and Testing (PICT). Clinical manifestation of STD such as Chlamydia includes Urethritis, Orchitis, Epididymitis, and Infertility in men to Endometritis, Cervicitis, PID, infertility, Perihepatitis and Salpingitis in women.

There is a 40% chance that Chlamydia would be infected to female from male; and a 30% chance that it will infected in male from female Hence, to curb such incidence, healthcare sector globally initiates national screening programmes and also provides incentives for voluntary screening. Thus, it leads to high test volume for Chlamydia and increases its market share.

There were similar screenings for HIV by healthcare departments, which would reach 2.1 billion by 2020. Laboratory testing is still significant for STD. HIV testing market would grow at a CAGR of 10.9% during the estimated time. There few STDs that can be detected with POC method. However, many POC devices are not approved by regulatory bodies such as USFDA due to specificity criteria and some deviations in the devices.

In the year 2013, STD testing devices accounted for $7.7 billion with laboratory testing retaining the most market share in terms of value. Europe is expected to witness a significant growth rate with its STD testing market poised to attain a mark of 26.8 billion by 2020 with a CAGR of 13.5%.

The report offers incisive data on the global Sexually Transmitted Diseases (STDs) Testing Market players with crucial analysis. Some of the key players listed in the report are:

• Roche Holdings AG
• BioMerieux
• Hologic Inc.
• Becton Dickinson & Company
• Cepheid Inc.
• Danaher Corporation
• Affymetrix
• Alere Inc.
• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• DiaSorin.

Related Post